scholarly article | Q13442814 |
P2093 | author name string | Ying He | |
Guiyun Jin | |||
Song Chen | |||
Xiaochun Ma | |||
Xiaohan Yin | |||
Siyu Lu | |||
Ziwei Hu | |||
Chuanzhu Lv | |||
P2860 | cites work | Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis | Q22010222 |
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species | Q28285451 | ||
Heparan sulphate proteoglycans fine-tune mammalian physiology | Q29619329 | ||
Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association | Q33337780 | ||
Versatile role of heparanase in inflammation | Q33770777 | ||
Mammalian heparanase: what is the message? | Q34652072 | ||
Roles of heparan-sulphate glycosaminoglycans in cancer | Q34718195 | ||
Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice | Q34876266 | ||
Syndecans in inflammation | Q35094731 | ||
Heparan Sulfate Core Proteins in Cell-Cell Signaling | Q35582990 | ||
High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression | Q35695593 | ||
The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis | Q35850606 | ||
Unfractionated heparin attenuates intestinal injury in mouse model of sepsis by inhibiting heparanase | Q35853992 | ||
Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness | Q36157201 | ||
Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation | Q36361058 | ||
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myeloma | Q36499443 | ||
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis | Q36787608 | ||
The anti-inflammatory effects of heparin and related compounds | Q36922642 | ||
Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma | Q36973696 | ||
The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. | Q37045970 | ||
Heparanase mediates renal dysfunction during early sepsis in mice. | Q37411095 | ||
The role of innate signaling in the homeostasis of tolerance and immunity in the intestine. | Q37604052 | ||
Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial | Q43779548 | ||
Treatment with unfractionated heparin attenuates coagulation and inflammation in endotoxemic mice. | Q53225041 | ||
Syndecan-1 and heparanase: potential markers for activity evaluation and differential diagnosis of Crohn's disease. | Q54267579 | ||
Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4 | Q75197360 | ||
Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease | Q77861798 | ||
Heparanase upregulation by colonic epithelium in inflammatory bowel disease | Q79241944 | ||
Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis | Q79906000 | ||
P433 | issue | 4 | |
P921 | main subject | sepsis | Q183134 |
P304 | page(s) | 241-249 | |
P577 | publication date | 2017-02-07 | |
P1433 | published in | Journal of Histochemistry and Cytochemistry | Q1523992 |
P1476 | title | Heparanase Mediates Intestinal Inflammation and Injury in a Mouse Model of Sepsis | |
P478 | volume | 65 |
Q89495589 | Both UFH and NAH alleviate shedding of endothelial glycocalyx and coagulopathy in LPS-induced sepsis |
Q92369060 | Modulation of Intestinal Epithelial Glycocalyx Development by Human Milk Oligosaccharides and Non-Digestible Carbohydrates |
Q46305715 | Regulation and function of endothelial glycocalyx layer in vascular diseases |
Q52725487 | Syndecan-1 shedding inhibition to protect against ischemic acute kidney injury through HGF target signaling pathway. |
Q47207922 | The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies. |
Q59340175 | Unfractionated heparin ameliorates pulmonary microvascular endothelial barrier dysfunction via microtubule stabilization in acute lung injury |
Search more.